Sign in

You're signed outSign in or to get full access.

John Civantos

Director at System1
Board

About John Civantos

Independent director at System1, Inc. (SST) since 2022; age 57. Senior Partner at Avance Investment Management (since Apr 2022); previously Co-Head of Private Capital Group at MSD Partners (2020–2022) and Managing Partner/Investment Committee member at Court Square Capital Partners (2004–2019), focused on Business Services and Technology. Education: BA (Duke), MBA (Wharton), MA in International Affairs (Johns Hopkins SAIS). Board has determined he is independent under NYSE and SEC rules. He serves on the Nominating & Corporate Governance Committee.

Past Roles

OrganizationRoleTenureCommittees/Impact
MSD Partners, L.P.Co-Head, Private Capital GroupAug 2020 – Mar 2022Co-led private capital investing activities
Court Square Capital PartnersManaging Partner; Investment Committee memberApr 2004 – Mar 2019Led Business Services and Technology sector investing

External Roles

OrganizationRoleTenureNotes
Avance Investment ManagementSenior PartnerApr 2022 – PresentPrivate equity; investment leadership

Board Governance

  • Independence: Independent director (NYSE/SEC) .
  • Committee assignments (2024–2025): Member, Nominating & Corporate Governance (Chair: Caroline Horn). Not a member of Audit or Compensation in 2024 or 2025 .
  • Attendance/engagement: Board met 6 times in 2024; each director attended ≥75% of Board and applicable committee meetings. Nominating & Corporate Governance Committee met 5 times in 2024; Audit met 10 times; Compensation met 4 times .
  • Board leadership: CEO serves as Chair; no Lead Independent Director; independents meet in executive session without management .
CommitteeRole2024 Meetings
Nominating & Corporate GovernanceMember5
AuditNot a member10
CompensationNot a member4

Fixed Compensation

YearStock Awards ($)Notes
2024190,000RSUs; amount consistent with $180k annual RSU + $10k Nominating & Gov’t Committee member RSU under the Non-Employee Director Compensation Program
2023189,998RSUs under Non-Employee Director Compensation Program
  • Structure: Non-employee directors receive equity (RSUs) as annual and committee awards; the program specifies $180k annual RSUs and additional RSUs for committee service (Nominating & Governance member: $10k). Reimbursement of reasonable expenses; no routine cash retainers disclosed; special committee cash fees in 2024 paid to other directors, not to Civantos .

Performance Compensation

Performance-linked elementDetail
None (for director pay)Director compensation is RSU-based and time-vested; proxy does not disclose performance metrics tied to non-employee director pay

Note: System1’s 2024 Stock Appreciation Rights Plan uses Adjusted EBITDA performance tranches ($50m/$60m/$70m/$80m) for eligible participants, including directors in plan terms, but the 2024 director compensation table shows only RSUs for directors and no SARs awarded to Civantos .

Other Directorships & Interlocks

CompanyExchange/TickerRoleCommitteesTenure
None disclosed in proxy biography
  • The proxy biography for Civantos does not list current public company directorships; prior experience is PE leadership (Avance, MSD Partners, Court Square). No interlocks with SST competitors/suppliers are disclosed for Civantos .

Expertise & Qualifications

  • Finance and investing: Two decades+ in private equity across Business Services and Technology sectors; investment committee experience .
  • Governance: Member of Nominating & Corporate Governance Committee; focus on board evaluation, governance guidelines, and director nominations .
  • Education: Duke (BA), Wharton (MBA), Johns Hopkins SAIS (MA) .

Equity Ownership

CategoryAmount
Directly held Class A shares (as of 4/15/2025)274,467
RSUs vesting within 60 days of 4/15/202531,667
Public Warrants (exercisable for Class A)100,000
John Civantos 2011 Family Trust (beneficial interest disclaimed except pecuniary)75,612
Unvested RSUs outstanding (as of 12/31/2024)63,334
Total beneficial Class A ownership (as of 4/15/2025)481,746; <1% of outstanding
  • Pledging/hedging: No pledging or hedging disclosures specific to Civantos found in the proxy .
  • Section 16 compliance: No delinquent filings listed for Civantos in 2024 or 2025 .

Governance Assessment

  • Strengths:

    • Independent director with deep PE and technology/business services experience; contributes to board composition diversity by skill set .
    • Active on Nominating & Corporate Governance Committee; committee met five times in 2024 indicating regular engagement .
    • Compensation alignment: Pay delivered entirely in equity RSUs (no routine cash retainer disclosed), reinforcing shareholder alignment; 2024 grant consistent with program structure including committee service .
    • Beneficial ownership includes direct shares and RSUs; no related-party transactions identified for Civantos .
  • Watch items:

    • Board structure: No Lead Independent Director, with CEO also serving as Chair; may concentrate authority and reduce independent oversight leverage .
    • Company-level control environment: The company disclosed material weaknesses in internal control over financial reporting and a 2024 auditor change; while not specific to Civantos, it elevates oversight demands on all directors .
    • Listing risk optics: 2025 proxy discusses NYSE minimum price deficiency and reverse split authorization; again company-wide, but governance scrutiny rises; directors may face increased investor engagement on remediation plans .
  • RED FLAGS (director-specific): None disclosed for Civantos—no attendance shortfalls, conflicts, related-party transactions, option repricings, or Section 16 delinquencies tied to him in the 2024–2025 proxies .